Facial skin cancers: General information and an overview of treatment methods

Postepy Dermatologii i Alergologii

Volumn 29, Issue 4, 2012, Pages 240-255

  Witmanowski, Henryk ^a,b   Lewandowicz, Edward ^c   Sobieszek, Daria ^c   Rykała, Jan ^c   Łuczkowska, Magdalena ^b  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^c MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Facial skin cancers; Non melanoma cancers of the face; Reconstruction; Treatment

Indexed keywords

ALPHA INTERFERON; BLEOMYCIN; FLUOROURACIL; PHOTOSENSITIZING AGENT;

ADULT; AGED; ALGORITHM; ARTICLE; BRACHYTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CRYOSURGERY; FACE; FACE SURGERY; HUMAN; MAJOR CLINICAL STUDY; NON MELANOMA SKIN CANCER; PHOTODYNAMIC THERAPY; PIGMENT DISORDER; POSTOPERATIVE COMPLICATION; RADIATION INJURY; SCAR; SKIN DEFECT; SKIN FLAP; SKIN GRAFT; SURGICAL INFECTION; TELERADIOTHERAPY;

EID: 84866791086     PISSN: 1642395X     EISSN: None     Source Type: Journal    
DOI: 10.5114/pdia.2012.30462     Document Type: Article

References (48)

1. Miller S. Etiology and pathogenesis of basal cell carcinoma. Clinics in Dermatology 1995; 13: 527-36. (Pubitemid 26101084)
2. Parkin DM, Pisani P, Ferley J. Global cancer statistics CA cancer J Clin 1999; 49: 33-64. (Pubitemid 29094960)
3. Adinarayan M, Krishnamurthy S. Clinicopathological evaluation of nonmelanoma skin cancer. Indian J Dermatol 2011; 56: 670-2.
4. Andrade P, Brites M, Vieira R, et al. Epidemiology of basal cell carcinomas and squamous cell carcinoma in Department of Dermatology - a 5 year reviev. An Bras Dermatol 2012; 87: 212-9.
5. Vitaliano PP, Urbach F. The relative importance of risk factors in nonmelanoma carcinoma. Arch Dermatol 1980; 116: 454-6. (Pubitemid 10147468)
6. Kordek, et al. Onkologia Podrȩcznik dla studentów i lekarzy. Via Medica, Gdańsk 2007; 41: 271-9.
7. Pearl DK, Scott EL. The anatomical distribution of skin cancers. Int J Epidemiol 1986; 15: 502-6. (Pubitemid 17229484)
8. Brash DE, Ziegler A, Jonason AS, et al. Sunlight and sunburn in human skin cancer: p53, apoptosis and tumor promotion. Invest Dermatol Symp Proc 1996; 1: 136-42.
9. Stern RS, Lange R. Non-melanoma skin cancer occurring in patients treated with PUVA five to ten years after first treatment. J Invest Dermatol 1988; 91: 120-4.
10. Ron E, Modan B, Preston D. Radiation-induced skin carcinomatosis of the head and neck. Radiation Res 1991; 125: 318.
11. Birkeland SA, Storm HH, Lamm LU, et al. Cancer risk after renal transplantation in the Nordic countries, 1964-1986. Int J Cancer 1995; 60: 183-9.
12. Franceschi S, Dal Maso L, Arniani S, et al. Risk of cancer other than Kaposi's sarcoma and non- Hodgkin's lymphoma in persons with AIDS registry linkage study. Br J Cancer 1998; 78: 966-70. (Pubitemid 28430030)
13. Hahn SB, Kim DJ, Jeon CH. Clinical study ofMarjolin's ulcer. Yonsei Med J 1990; 31: 234.
14. Yuspa SH. Cutaneous chemical carcinogenesis. J Am Acad Dermatol 1986; 15: 1031-44. (Pubitemid 17176818)
15. Glogau RG. Actinic keratoses - scientific evaluation and public health implications: the risk of progression to invasive disease. J Am Acad Dermatol 2000; 42: 23-4.
16. Stone N, Reed J, Mahood J, et al. Xeroderma pigmentosum, the role of photo testing. Br J Dermatol 2000; 143: 595-7.
17. Mc Kenna KE, Somerville JE, Walsh MY, et al. Basal cell carcinoma occurring in association with dermatofibroma. Dermatology 1993; 187: 54-7. (Pubitemid 23189231)
18. Jones EW, Heyl T. Naevus sebaceous: a report of 140 cases with special regard to the development secondary malignant tumors. Br J Dermatol 1970; 82: 99-117.
19. Wyrzykowska N, Wiȩckowicz-Rosińska A, Bartoszak L, et al. Bowen's disease and basal cell carcinoma in a renal transplant recipient - case report. Postep Derm Alergol 2011; 28: 138-41.
20. Graham JH, Helwig EB. Bowen's disease and its relationship to systemic cancer. Arch Dermatol 1959; 80: 133-59.
21. Lever WF. Tumors and cysts of the epidermis. In: Histopathology of the skin. Lever WF, Schaumberg-Lever S (eds). 7th ed. JB Lippincott, Philadelphia 1990; 546.
22. Konigova R, Rychterova V. Majrolin's ulcer. Acta Chir Plast 2000; 42: 91.
23. Takata M. Nevoid basal cell carcinoma syndrome. Nippon Rinsho 2000; 58: 1376-80.
24. Lacour JP. Carcinogenesis of basal cell carcinomas: genetics and molecular mechanisms. Br J Dermatol 2002; 146 (Suppl 61): 17-9. (Pubitemid 34437805)
25. Gherardini G, Bhatia N, Stal S. Congenital syndromes associated with nonmelanoma skin cancers. Clin Plast Surg 1997; 24: 655.
26. Wong CMS, Strange RC, Lear JT. Clinical review. Basal cell carcinoma. BMJ 2003; 327: 794-8. (Pubitemid 37211176)
27. Scrivener Y, Grosshans E, Cribier B. Variations of basal cell carcinomas according to gender, age, location, and histopathological subtype. Br J Dermatol 2002; 147: 41-7. (Pubitemid 34779436)
28. Telfer N, Colver G, Morton C. Guidelines fort he menagement of basal cell carcinoma. Br J Dermatology 2008; 159: 35-48. (Pubitemid 351874512)
29. Sartore L, Lancerotto L, Salmaso M, et al. Facial basal cell carcinoma: analysis of recurrence and follow up strategies. Oncol Rep 2011; 26: 1423-9.
30. Silverman MK, Kopf AW, Bart RS. Recurrence rates of treated basal cell carcinomas: surgical excision. J Dermatol Surg Oncol 1992; 18: 471.
31. Rove DE, Carrol RJ, Day CL Jr. Prognostic factors for local recurrence metastasis and survival rates in squamous cell carcinoma of the skin, ear and lip. Implications for treatment modality selection. J Am Acad Dermatol 1992; 266: 976-90.
32. Broders AC. Squamous-cell epithelioma oft he skin. Ann Surg 1921; 73: 141.
33. Mathes SJ. Plastic surgery. Vol. 5. Saunders Elsevier, Phi la delphia 2006.
34. Rank BK, Wakefield AR. Surgery of basal cell carcinoma. Br J Surg 1958; 45: 531-47.
35. Lukic D, Karabeg R, Jeremic P, et al. The results of treatment of basocdellular carcinomas of the head skin. Med Arh 2012; 66: 169-72.
36. Anthony ML. Surgical treatment of nonmelanoma skin cancers. AORN J 2000; 71: 552-4.
37. Geisse JK. Comparison of treatment modalities for squamous cell carcinoma. Clin Dermatol 1995; 13: 621-6. (Pubitemid 26101095)
38. Salasche SJ. Status of curettage ad desiccation in the treatment of rimary basal cell carcinoma. J Am Acad Dermatol 1984; 10: 285-7.
39. Lowrence CM. Moh's micrographic surgery for basal cell carcinoma. Clin Exp Dermatol 1999; 24: 130-3.
40. Veronese F, Farinelli P, Zavatarro E, et al. Basal cell carcinoma oft he head region: therapeutic results of 350 lesions treated with Mohs micrographic surgery. J Eur Dermatol Venerol 2012; 26: 838-43.
41. Goette DK. Topical chemotherapy with 5-fluorouracil. J Am Acad Dermatol 1981; 6: 633-49.
42. Gargiulo M, Papa A, Capasso P, et al. Electrochemotherapy for non-melanoma head and neck cancers: clinical outcomes in 25 patients. Ann Surg 2012; 255: 1158-64.
43. Chimenti S, Peris K, Di Cristofaro S, et al. Use of recombinant interferon alfa-2b in the treatment of basal cell carcinoma. Dermatology 1995; 190: 214-7.
44. Nag S, Caro ER, Demanes JD, et al. The American Brachytherapy Society recommendations for high dose rate brachytherapy for head and neck carcinoma. Int J Oncol Biol Phys 2001; 50: 1190-8.
45. Locke J, Karimpour S, Young G, et al. Radiotherapy for epithelial skin cancer. Int J Radiat Oncol Bio Phys 1990; 19: 235-42.
46. Kuflik EG, Gage A. The five-year cure rate achieved by cryosurgery for skin cancer. J Am Acad Dermatol 1991; 24: 1002-4.
47. Gaitanis G, Alexopoulos EC, Bassukas ID. Cryosurgery is more effective in the treatment of primary, non superficial basal cell carcinomas when applied during and not prior to five week imiquimod course: a randomized, prospective, open-label study. Eur J Dermatol 2012; 21: 952-8.
48. Flechter S, Skaria A, Nievergelt H, et al. Facial basal cell carcinomas recurring after photodynamic therapy: a retrospective analysis of histological subtypes. Dermatology 2012; 224: 346-51.